⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1706668 | 0.83 | — | — | |
| SCHEMBL2051101 | 0.79 | — | — | |
| SCHEMBL9405105 | 0.79 | — | — | |
| SCHEMBL4984798 | 0.77 | — | — | |
| SCHEMBL1122688 | 0.77 | — | — | |
| SCHEMBL3252538 | 0.77 | — | — | |
| SCHEMBL6266389 | 0.77 | — | — | |
| SCHEMBL1456355 | 0.77 | — | — | |
| SCHEMBL3980860 | 0.77 | — | — | |
| SCHEMBL7684349 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110621317-B | Inhibitors of Histone Deacetylase (HDACS) | 安基生技新药股份有限公司 | 2023-05-12 | — | — | CN | claimed |
| US-11535598-B2 | Histone deacetylases (HDACs) inhibitors | Annji Pharmaceutical Co., Ltd. (TW) | 2022-12-27 | — | — | US | claimed |
| EP-3624804-B1 | HISTONE DEACETYLASES (HDACS) INHIBITORS | ANNJI PHARM CO LTD (TW) | 2022-02-16 | — | — | EP | claimed |
| US-20210355089-A1 | HISTONE DEACETYLASES (HDACS) INHIBITORS | Annji Pharmaceutical Co., Ltd. (TW) | 2021-11-18 | — | — | US | claimed |
| CN-110621317-A | Histone Deacetylase (HDACS) inhibitors | 安基生技新药股份有限公司 | 2019-12-27 | — | — | CN | claimed |
| US-20170313661-A1 | KINASE MODULATORS FOR THE TREATMENT OF CANCER | SYNOVO GMBH (DE) | 2017-11-02 | — | — | US | claimed |
| EP-2407511-B1 | Thermoplastic resin composition | CHEIL IND INC (KR) | 2017-03-22 | — | — | EP | claimed |
| US-20140323487-A1 | Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors | GLAXOSMITHKLINE LLC | 2014-10-30 | — | — | US | claimed |
| EP-1555266-B1 | REMEDIES OR PREVENTIVES FOR URINARY INCONTINENCE AND MORPHINAN DERIVATIVES HAVING NITROGEN-CONTAINING HETEROCYCLIC GROUP | TORAY INDUSTRIES (JP) | 2014-05-21 | — | — | EP | claimed |
| WO-2013046041-A1 | PYRIDINYLPYRAZOLES FOR USE AS KINASE MODULATORS FOR THE TREATMENT OF CANCER | SYNOVO GMBH (DE) | 2013-04-04 | — | — | WO | claimed |
| EP-1555266-A1 | REMEDIES OR PREVENTIVES FOR URINARY FREQUENCY OR URINARY INCONTINENCE AND MORPHINAN DERIVATIVES HAVING NITROGEN-CONTAINING HETEROCYCLIC GROUP | TORAY INDUSTRIES, INC. (JP) | 2005-07-20 | — | — | EP | claimed |
| US-20050070564-A1 | Oripavine derivatives and their uses as medicines | ZHEJIANG XIANJU PHARMACEUTICALS CO., LTD. (CN) | 2005-03-31 | — | — | US | claimed |
| US-20040166137-A1 | Hetero-substituted benzimidazole compounds and antiviral uses thereof | TRIMERIS, INC. | 2004-08-26 | — | — | US | claimed |
| EP-1439179-A1 | NEW ORIPAVINE DERIVATIVES AND THEIR USES AS MEDICINES | Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China (CN) | 2004-07-21 | — | — | EP | claimed |
| US-20030119754-A1 | Benzimidazole compounds and antiviral uses thereof | TRIMERIS, INC. | 2003-06-26 | — | — | US | claimed |
| WO-2002092575-A1 | BENZIMIDAZOLE COMPOUNDS AND ANTIVIRAL USES THEREOF | TRIMERIS, INC. (US) | 2002-11-21 | — | — | WO | claimed |
| CN-1061213-C | Combating fish parasites | BAYER AG (DE) | 2001-01-31 | — | — | CN | claimed |
| CN-1200725-A | Acylaminosalicyclic acid amide compound | BAYER AG (DE) | 1998-12-02 | — | — | CN | claimed |
| EP-0617618-A1 | ARYL-TRIFLATES AND RELATED COMPOUNDS | WIKSTRÖM, Hakan Vilhelm (NL) | 1994-10-05 | — | — | EP | claimed |
| WO-1993011761-A1 | ARYL-TRIFLATES AND RELATED COMPOUNDS | H. LUNDBECK A/S (DK) | 1993-06-24 | — | — | WO | claimed |